细胞培养基血清替代物与无血清培养试剂优势解析
围绕细胞培养基血清替代物，分析无血清培养试剂在批次稳定性、成分可追溯和工艺放大中的优势，并给出研发质控建议。
2026-10-21
Views 65
AI
Process Scale-Up and Cost Control in Large-Scale Production of Recombinant Proteins
Focusing on the process scale-up of recombinant proteins from the laboratory to large-scale production, discuss core ind...
2026-09-24
Views 127
AI
Production Challenges and Regulatory Development Observations in the Industrialization of Lentiviral Products
As the field of cell and gene therapy gains momentum, the industrial demand for lentiviral products continues to grow. T...
2026-09-24
Views 105
AI
How We Publish
1TopicIndustry trends and user questions
2WriteHuman-written, AI-assisted or licensed
3LinkRelated products on every article
4PublishSynced to PC and mobile
Content Promise
✓Sources are cited
✓Technical articles reviewed
✓AI content is labeled
✓Infringement removed in 24h